Clinical Trials Logo

Constriction, Pathologic clinical trials

View clinical trials related to Constriction, Pathologic.

Filter by:

NCT ID: NCT05709652 Recruiting - Clinical trials for Cardiovascular Diseases

Impact of Fast-rotation Coronary CT in Patients Undergoing Aortic Stenosis Workup

FAST-CCT
Start date: February 27, 2024
Phase: N/A
Study type: Interventional

This study aims to evaluate the clinical value of a novel CT gantry supporting a .23 second rotation time and systematically compare it with 0.23 second rotation time, in patients with clinically indicated aortic CTA in the workup of aortic stenosis. Patients will be randomly assigned .23 or .28 sec rotation time CTA. Coronary artery interpretability rates will be determined in both groups.

NCT ID: NCT05708118 Recruiting - Heart Diseases Clinical Trials

Progression of Ascending Aorta Diameters in Bicuspid Aortic Valve After Transcatheter or Surgical Replacement.

ARDITAV
Start date: January 20, 2023
Phase:
Study type: Observational

The goal of this prospective, non-randomized, single-center, observational study is to assess whether there is a progressive dilation of ascending aorta after surgical or transcatheter aortic valve replacement (TAVR) in patients who underwent elective aortic valve replacement or TAVR for stenotic bicuspid aortic valve (BAV) at our institution from 2015 to June 2022. Participants will undergo both a CT and an echocardiographic assessment at least 90 days after surgery.

NCT ID: NCT05701410 Recruiting - Spinal Stenosis Clinical Trials

Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.

CASS-I
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The study investigates the prevalence of cardiac amyloidosis among patients with a history of lumbar spinal stenosis within the last ten years in the region of central Denmark.

NCT ID: NCT05701397 Recruiting - Spinal Stenosis Clinical Trials

Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis.

CASS-II
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Patients undergoing surgery for lumbar spinal stenosis will have biopsies of the ligamentum flavum sent to the department of pathology for histologic screening. If the ligament biopsy contains amyloid, patients will receive an echocardiogram, an ecg, biomarker testing, and a bone tracer scintigraphy diagnostic of cardiac amyloidosis.

NCT ID: NCT05700266 Not yet recruiting - Ischemic Stroke Clinical Trials

Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis

AA-ICAS
Start date: December 30, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The primary goal of the clinical trial is to test the effect of oral rivaroxaban plus aspirin in patients with recent stroke/ transient ischemic attack (TIA) caused by intracranial artery stenosis. Participants will be divided into 2 groups to receive either oral rivaroxaban plus aspirin or oral clopidogrel plus aspirin. The main question it aims to answer is whether the experimental group (oral rivaroxaban plus aspirin) is superior to the control group ( oral clopidogrel plus aspirin) to lower recurrent stroke/TIA or death in these patients during 1 year of follow-up.

NCT ID: NCT05696470 Active, not recruiting - Radiculopathy Clinical Trials

Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs

Start date: March 31, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of this trial is to assess fusion rates in 3 and 4 level ACDFs in patients implanted with DePuy Conduit 3D printed titanium cages supplemented with SKYLINE Anterior Cervical Plate System and 1 CC DBM. This will be a non-inferiority study, looking to show that Synthes Conduit 3D printed titanium cages fuse as well as cages.

NCT ID: NCT05696145 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

Aortic Stenosis Associated Left Ventricular Remodeling - An Investigation of Genetic and Gender Specific Differences in 170 Patients Undergoing Aortic Valve Replacement Surgery

SALVAGE
Start date: March 1, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this study is to investigate the genetic and gender specific differences, in patients with low flow low gradient aortic stenosis and high flow high gradient aortic stenosis. Patients referred for surgical aorticvalve replacement will be offered to participarte in the study. The main questions the study aims to answer are: 1. Low-gradient aortic stenosis is associated with differences in valvular concentration of the genes that code for mast-cell chymase, Angiotensin-II, ACE, ACE2 and Angiotensin receptor 1 and 2. 2. Low-gradient aortic stenosis is associated with differences in the genetic code of renin-angiotensin-aldosterone system. 3. Gender differences in LV remodelling associates with different levels of sexual hormones. Patients participating in the study will be asked to undergo: - Cardiac ultrasound, MR- and CT-scan prior to surgery - Blooddraw prior to surgery. - Heartmuscle biopsy during surgery - Cardiac MR-scan 1 year after surgery.

NCT ID: NCT05692882 Recruiting - Drug-Eluting Stents Clinical Trials

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Start date: November 16, 2023
Phase: N/A
Study type: Interventional

The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.

NCT ID: NCT05682651 Completed - COVID-19 Clinical Trials

Relationship Between Post-Intubation Tracheal Stenosis and Covid-19

Start date: December 28, 2022
Phase:
Study type: Observational

Tracheal stenosis (TS) is a serious complication that occurs in approximately 6-22% of patients due to prolonged endotracheal intubation. Cuff hyperinflation of the endotracheal tube, use of large tubes, advanced age, female gender, smoking, obesity, and diabetes are risk factors for TS. The most common and serious complication in COVID-19 patients is acute respiratory distress syndrome (ARDS), which requires oxygen and ventilation treatments. In the literature, it is reported that 9.8-15.2% of patients need invasive mechanical ventilation (IMV). The concern of aerosol formation and prone position applications that emerged with the coronavirus pandemic caused delays in tracheostomy decisions and the use of uncontrolled high cuff pressures, paving the way for TS. The capillary perfusion pressure of the tracheal mucosa ranges from 20 to 30 mmHg. A cuff pressure of the endotracheal tube above 30 mmHg causes mucosal ischemia. Cartilage inflammation due to ischemic injury may be partial or full thickness. Depending on the degree of inflammation in the affected tracheal segments, stenosis and even perforation may develop. It is aimed to determine the etiological causes, to determine how much of the total TS cases covid-related TS constitutes, to examine the treatments and patient results in covid/non-covid TS. This study will contribute to the measures that can be taken during and after the care process in the intensive care unit.

NCT ID: NCT05678413 Recruiting - Stricture Urethra Clinical Trials

Role of Paclitaxel in Stricture Urethra

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Stricture urethra is a common disease and has various causing factors. The most common performed procedure is direct visual internal urethrotomy (DVIU), but unfortunately has a high recurrence rates. Multiple trial were performed to improve the outcomes of DVIU. Various intralesional injections were used. in this trial we will evaluate intralesional paclitaxel injection following DVIU.